NCAM expression has also been detected in many malignancies, e.g. in neuroblastoma, rhabdomyosarcoma, non-small cell lung carcinoma (NSCLC), small cell lung cancer (SCLC), brain tumors, myelomas and acute myeloid leukemia [3-9]. Here, NCAM1 is linked to rhabdomyosarcoma.